Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Depreciation & Amortization - Total (2022 - 2025)

Historic Depreciation & Amortization - Total for InMed Pharmaceuticals (INM) over the last 4 years, with Q2 2025 value amounting to $12206.0.

  • InMed Pharmaceuticals' Depreciation & Amortization - Total rose 12437.5% to $12206.0 in Q2 2025 from the same period last year, while for Dec 2025 it was $24409.0, marking a year-over-year decrease of 4630.07%. This contributed to the annual value of $50204.0 for FY2025, which is 515.69% up from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Depreciation & Amortization - Total of $12206.0 as of Q2 2025, which was up 12437.5% from $12203.0 recorded in Q1 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Depreciation & Amortization - Total peaked at $14242.0 during Q4 2023, and registered a low of $5440.0 during Q2 2024.
  • In the last 4 years, InMed Pharmaceuticals' Depreciation & Amortization - Total had a median value of $12209.0 in 2024 and averaged $11773.0.
  • Per our database at Business Quant, InMed Pharmaceuticals' Depreciation & Amortization - Total plummeted by 5788.17% in 2024 and then surged by 12437.5% in 2025.
  • Quarter analysis of 4 years shows InMed Pharmaceuticals' Depreciation & Amortization - Total stood at $8056.0 in 2022, then skyrocketed by 76.79% to $14242.0 in 2023, then decreased by 14.27% to $12209.0 in 2024, then decreased by 0.02% to $12206.0 in 2025.
  • Its last three reported values are $12206.0 in Q2 2025, $12203.0 for Q1 2025, and $12209.0 during Q4 2024.